en-USen-GB

The eSource Readiness Assessment Tool (eSRA) contains questions based on regulations and regulatory agency guidelines for clinical research data sources and should be used to evaluate the suitability of an Investigator Site computerized system to provide data for clinical research.

Clinical research draws on a combination of data collected during a clinical trial and historical medical information relating to the research subject(s).  Many of the data points needed for clinical research are originating in Electronic Health Record Systems, making them “eSource” for clinical research.  Even if these data points are not used in their electronic state for clinical research, but are printed from the electronic health records and then re-entered into a Sponsor's system for a clinical trial, the source of the information (the healthcare system) must still be confirmed as compliant with standards set forth in clinical research regulations and applicable guidance documents.

An eClinical Forum team, comprised of CRAs and Data Managers from different clinical research sponsor organizations and CROs, has produced the "eSource-Readiness Assessment", otherwise known as "eSRA" for sites to perform a self-assessment of their computerized systems ability to be compliant with clinical research regulations. 

                      The eSRA Template Version 2019 can be downloaded as part of the eSRA Handbook below. 

Stay Current!!  As new regulations are released or updated, the eClinical Forum will evaluate if the eSRA questions should be updated. To be notified of future releases of the eSRA Template, please send an email to eSRA@eClinicalForum.org. Your email address will not be used for purposes other than to inform you of updates to eSRA. 

eSRA Resources

Netherlands initiative to assess electronic health record systems using eCF eSRA tool

Published on Wednesday, February 17, 2016

Netherlands initiative to assess electronic health record systems using eCF eSRA tool

Partnering for Success

NL initiative to assess electronic health record systems using eCF eSRA tool

The Dutch Clinical Trial Foundation (DCTF) has endorsed an EHR working group committed to the implementation of one uniform tool for the validation of electronic health record (EHR) systems used at clinical research sites within the Netherlands. The group consists of representatives from several pharmaceutical companies, CROs and hospitals, and is chaired by Martijn Griep, Johnson & Johnson Regional QC Manager, coordinated by Dana De Beuckelaer-Dournez from the University of Antwerp.

After considerable research and discussion with national stakeholders, the working group has chosen to use the eSRA (eSource-Readiness Assessment) program to harmonize the review of the EHR systems and to prove compliance against appropriate clinical research regulations and guidances. eSRA is provided for free by the eClinical Forum (a non-profit, non-commercial discussion/action group comprised of members of the Pharmaceutical and Clinical Research Services industry).This tool is intended to make the clinical research process more efficient, while furthering the use of EHR records for clinical research. Clinical research sites are often asked by their clinical trial sponsors to complete questionnaires regarding their EHR system. With each sponsor having its own questionnaire, completing a different form for each sponsor can be very time consuming. By using the eSRA system to complete a standard form, they can do it once and provide it to all their sponsors. And, since eSRA is based on the EMA and FDA regulations, the resulting report is appropriate to share with regulators.

The EHR working group started a pilot in three big hospitals to assess their systems using eSRA. Ellen Rusch, scientific member Scientific Institution, Martini Hospital Groningen and one of the members of the working group, was the first to complete the process.. She reported that the website that hosts the eSRA system was easy to use without any training.  She worked with her IT support staff, and together they were able to complete the assessment in only 30 minutes! “We do about 50-80 trials each year and we are receiving a new sponsor questionnaire to complete about every 2 weeks. Each sponsor has their own form with questions worded differently, so it is very time consuming to work through each questionnaire. Each sponsor form takes an hour or more to read the new form, determine the answers and file the form. Then we must wait for the sponsor to review the form and sometimes re-work if there are any errors, etc. Some pharma-provided forms can be rather long, even though they all seem to ask the same questions, just in a different format each time. By doing the eSRA assessment once, knowing that it has been completed correctly, and providing the resulting report to the sponsors, we will save a lot of time. In addition, by registering for notifications, the eSRA system will notify us if any clinical research regulations have changed that we should be aware of.”

Martijn Griep, J&J, says “The completion of an eSRA assessment by the Martini Hospital is an important first step towards the registration of more sites and towards gaining the interest of large EHR system vendors to cooperate. By having the EHR vendors complete a pre-assessment of their systems, eSRA can be even more efficient, as these vendor assessments will be used as a resource for our clinical research sites when they complete their site assessments, so that all sites in the NL can use eSRA to assess their systems. Our vision is that all clinical research sites in the Netherlands will be assessed using eSRA and to facilitate eSRA recognition by all sponsors and regulators. We are very grateful to the eClinical Forum for providing this free tool.”

The EHR working group is planning further roll out to more clinical research sites in the NL and mutual acceptance by pharmaceutical companies such that eSRA can replace their own questionnaires. They believe this will avoid duplication of efforts by the completion of various forms and it will contribute to more efficient and reliable data collection in clinical trials.

 

Rate this article:
No rating
Comments (0)Number of views (11781)

Author: Webmaster

Categories: TOPICS, Regulatory, Healthcare, WORKING GROUPS, eSRA

Tags:

Print

More links

Theme picker